Clinical Trial Update: Toripalimab With Chemotherapy for Sinus Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating toripalimab in combination with chemotherapy for sinonasal cancer and related paranasal sinus neoplasms is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Paranasal Sinus Cancer
• Sinonasal Cancer
• Sinonasal Squamous Cell Carcinoma
• Sinonasal Undifferentiated Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Glenn J. Hanna | Conditions: Sinonasal Cancer, Paranasal Sinus Neoplasms | Phase 2 | Status: RECRUITING